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Introduction {#sec005}
============

Dengue is the most common and serious arthropod-borne viral disease. First reported in 1779 by David Bylon during an epidemic in Indonesia, there has been a dramatic expansion in disease distribution in the last 50 years \[[@pone.0157631.ref001]\]. Before 1970, only nine countries had dengue epidemics. Currently, dengue is endemic in more than a hundred countries in five out of the six WHO regions \[[@pone.0157631.ref002]\]. It is estimated that there are 2.5 billion people living in dengue-endemic countries \[[@pone.0157631.ref003], [@pone.0157631.ref004]\].

Nearly 75% of the global dengue disease burden is in the WHO South East Asia and Western Pacific regions \[[@pone.0157631.ref003], [@pone.0157631.ref004]\]. Dengue was first reported in 1902 in Penang, Malaysia \[[@pone.0157631.ref005]\]. The incidence rate of dengue in Malaysia had quadrupled from 44.3 cases/100 000 in 1999 to 181 cases/100 000 in 2007 \[[@pone.0157631.ref006]\] and the number of reported dengue cases has increased 6.5 fold in the last decade \[[@pone.0157631.ref007]\]. Since 2001, the fatality rate has been 2 to 3 in a thousand cases except for 2007 where it increased to 6 in a thousand \[[@pone.0157631.ref006], [@pone.0157631.ref007]\]. The high dengue incidence, and its possible complications and fatalities, has posed a huge burden on the national health care system. During dengue epidemics, vital resources including time, hospital beds, finances and personnel are diverted from other serious disease areas.

Dengue has a wide spectrum of clinical presentations and its clinical course can be unpredictable \[[@pone.0157631.ref008]\]. The WHO 1997 guidelines classified dengue into undifferentiated fever, dengue fever and dengue haemorrhagic fever (DHF). DHF was further classified into four severity grades with grade 3 and 4 defined as dengue shock syndrome (DSS) \[[@pone.0157631.ref009]\]. However, difficulties in applying the criteria in clinical practice have led to a revision of the classification with the disease classified as severe and non-severe dengue with or without warning signs \[[@pone.0157631.ref008]\].

A study in Singapore of 596 dengue cases found that female gender, lower than normal haematocrit levels, abdominal distension, vomiting and fever on admission were factors associated with severe dengue \[[@pone.0157631.ref010]\]. Another study on 560 dengue patients in France found that plasma leakage, severe thrombocytopenia and acute hepatitis were associated with increased mortality \[[@pone.0157631.ref011]\]. Abdominal pain, cough and diarrhoea were found to predict development of severe complications \[[@pone.0157631.ref011]\]. In Vietnam, young age and female gender were found to be associated with dengue mortality \[[@pone.0157631.ref012]\]. Similar findings were shown in a meta-analysis by Huy et al. \[[@pone.0157631.ref013]\].

The identification of variables associated with poor outcomes assists health care practitioners to focus on patients at higher risk and facilitate patient flow. Therefore, this study aimed to determine the factors associated with dengue-related mortality in a cohort of patients in the Malaysian dengue registry in 2013.

Materials and Methods {#sec006}
=====================

This was a retrospective cohort study of all patients in the 2013 Malaysian national dengue (e-Dengue) registry. In Malaysia, all cases of dengue diagnosed by clinical suspicion or serological confirmation must be reported to the district health authorities using an online notification system (e-Notice). Data on socio-demographic characteristics, clinical features at notification, full blood count and disease diagnosis were sent through e-Notice. The district health authorities verified the diagnosis using the WHO 1997 criteria of acute febrile illness with two or more dengue manifestations \[[@pone.0157631.ref009]\]. A probable dengue case was defined as an acute febrile illness with two or more clinical manifestations (headache, retro-orbital pain, myalgia, arthralgia, rash, hemorrhagic manifestations, leukopenia) in addition to supportive serology or occurrence at the same location and time as other confirmed cases of dengue fever. A confirmed dengue case is one confirmed by laboratory criteria such as dengue virus isolation, a fourfold rise in antibody titres, virus antigen detection or virus genomic sequence detection \[[@pone.0157631.ref009]\]. The data was then entered into the e-Dengue registry at the district health office.

In this study, data was analysed using SPSS statistical software package (version 22.0; SPSS, Chicago, IL, USA). The outcome measure used was dengue-related mortality. Socio-demographic and clinical data were described using proportions. Continuous variables were checked for normality. Associations between variables and outcomes were first analysed using univariate analysis. Variables with a p-value of less than 0.25 were selected for inclusion into the multivariate analysis model \[[@pone.0157631.ref014]\]. However, variables were only considered as significant if the multivariate analysis showed that the association had a p-value of less than 0.05. Multivariate analysis was performed using the Enter method.

Names and identifiers of the patients in the registry were anonymised and kept confidential. The study was approved by the Malaysian Research Ethics Committee, NMRR-14-1275-22205.

Results {#sec007}
=======

In 2013, there were 43 347 cases of dengue entered into the registry. There were 96 deaths, of which 92 were attributed to dengue. Of the dengue deaths, 8 were children, who were less than 15 years of age. The overall dengue case fatality rate was 0.2%.

[Table 1](#pone.0157631.t001){ref-type="table"} shows a summary of socio-demographic characteristics of the cohort. The mean age was 30.0 years (SD 15.7) with more men than women. Most cases were from urban areas. The incidence of dengue increased towards the later part of the year ([Fig 1](#pone.0157631.g001){ref-type="fig"}).

![Number of dengue cases in Malaysia between December 2012-December 2013.\
\* All months are in 2013 unless otherwise stated.](pone.0157631.g001){#pone.0157631.g001}
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###### Socio-demographic characteristics of patients with dengue in Malaysia in 2013 (n = 43347).

![](pone.0157631.t001){#pone.0157631.t001g}

  Socio demographic characteristics   Total n (%)    Alive, n (%)   Dead, n (%), n = 92
  ----------------------------------- -------------- -------------- ---------------------
  **Age (n = 43347)**                                               
  Mean (SD) (years)                   30.0 (15.7)    30.0 (15.7)    41.8 (20.5)
  Median (years)                      28.0           28.0           42.5
  Range (years)                       \<1--96        \<1--96        \<1--84
  **Gender (n = 43347)**                                            
  Male                                26086 (60.2)   26042 (60.2)   42 (45.7)
  Female                              17261 (39.8)   17209 (39.8)   50 (54.3)
  **Nationality (n = 43347)**                                       
  Malaysian                           29665 (91.5)   39574 (91.5)   87 (94.6)
  Non Malaysian                       3682 (8.5)     3677 (8.5)     5 (5.4)
  **Ethnicity (n = 39662)**                                         
  Malay                               23486 (54.2)   23433 (59.2)   50 (57.5)
  Chinese                             10045 (23.2)   10021 (25.3)   24 (27.6)
  Indian                              4223 (9.7)     4216 (10.7)    6 (6.9)
  Indigenous West Malaysia            172 (0.4)      172 (0.4)      0 (0.0)
  Indigenous Sarawak                  920 (2.1)      917 (2.3)      3 (3.4)
  Indigenous Sabah                    567 (1.3)      563 (1.4)      4 (4.6)
  Others                              249 (0.6)      249 (0.6)      0 (0.0)
  **Place of dwelling (n = 38084)**                                 
  Urban                               32061 (84.2)   31990 (84.2)   68 (80.0)
  Rural                               6023 (15.8)    6005 (15.8)    17 (20.0)

[Table 2](#pone.0157631.t002){ref-type="table"} summarizes clinical manifestations at notification. The five most common accompanying features were body or joint ache, headache, nausea and/or vomiting, abdominal symptoms and rash.

10.1371/journal.pone.0157631.t002

###### Clinical manifestations at notification (n = 43347).
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  Clinical manifestation                                      Total n (%)    Alive n (%), n = 43255   Dead, n (%), n = 92
  ----------------------------------------------------------- -------------- ------------------------ ---------------------
  Body or joint ache                                          37209 (85.8)   37134 (85.8)             73 (79.3)
  Headache                                                    32913 (75.9)   32849 (75.9)             63 (68.5)
  Nausea and/or vomiting                                      14917 (34.4)   14867 (34.4)             47 (51.1)
  Abdominal symptoms                                          12489 (28.8)   12455 (28.8)             31 (33.7)
  Rash                                                        6700 (15.5)    6689 (15.5)              11 (12.0)
  Suborbital pain                                             1655 (3.8)     1653 (3.8)               2 (2.2)
  Bleeding                                                    864 (2.0)      856 (2.0)                7 (7.6)
  Abdominal pain or tenderness                                805 (1.9)      801 (1.9)                3 (3.3)
  Lethargy and/or restlessness                                316 (0.7)      310 (0.7)                6 (6.5)
  Persistent vomiting                                         64 (0.1)       62 (0.1)                 2 (2.2)
  Severe plasma leakage                                       27 (0.1)       25 (0.1)                 2 (2.2)
  Liver enlargement 2cm                                       5 (\<0.1)      5 (\<0.1))               0 (0.0)
  Shock                                                       4 (\<0.1)      1 (\<0.1)                3 (3.3)
  Clinical fluid accumulation                                 2 (\<0.1)      2 (\<0.1)                0 (0.0)
  Organ failure (kidney/liver/central nervous system/heart)   2 (\<0.1)      1 (\<0.1)                1 (1.1)
  Severe bleeding                                             0 (0.0)        0 (0.0)                  0 (0.0)

Serological testing was done in 69.3% (30020) of the cohort of which 13081 were positive, 1210 were negative, 39 were equivocal and 15690 had no documented results. [Table 3](#pone.0157631.t003){ref-type="table"} shows the univariate and multivariate analysis of possible factors of dengue-related mortality (n = 41) in the serologically positive population. Multivariate analysis in those with confirmed dengue shows that increasing age, persistent vomiting, bleeding and severe plasma leakage were associated with mortality.

10.1371/journal.pone.0157631.t003

###### Univariate and multivariate analysis (n = 13081) of dengue mortality in serologically-confirmed cases.
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  Variables                           Alive n (%)    Dengue-related death, n (%)   Univariate analysis, OR (95% CI)   p         Multivariate analysis, OR (95% CI)   p
  ----------------------------------- -------------- ----------------------------- ---------------------------------- --------- ------------------------------------ ---------
  **Mean Age, years (SD)**            30.7 (15.86)   37.6 (21.19)                  1.03 (1.01--1.04)                  0.006     1.03 (1.01--1.05)                    0.002
  **Gender**                                                                                                                                                         
  Male                                7580 (99.7)    19 (0.3)                      1                                            1                                    
  Female                              5458 (99.6)    22 (0.4)                      1.61 (0.87--2.97)                  0.130     1.49 (0.80--2.78)                    0.214
  **Nationality**                                                                                                                                                    
  Malaysian                           12188 (99.7)   38 (0.3)                      1                                                                                 
  Non Malaysian                       850 (99.6)     3 (0.4)                       1.13 (0.35--3.68)                  0.836                                          
  **Race (n = 39658)**                                                                                                0.580                                          
  Malay                               6011 (99.7)    18 (0.3)                      1                                                                                 
  Chinese                             4015 (99.7)    13 (0.3)                      48.38 x 10^5^                      0.997                                          
  Indian                              1241 (99.8)    2 (0.2)                       52.30 x 10^5^                      0.997                                          
  Indigenous people                   848 (99.4)     5 (0.6)                       26.03 x 10^5^                      0.998                                          
  Others                              71 (100.0)     0 (0.0)                       95.25 x 10^5^                      0.997                                          
  **Place of dwelling (n = 38080)**                                                                                                                                  
  Urban                               9642 (99.7)    32 (0.3)                      1                                                                                 
  Rural                               1920 (99.6)    7 (0.4)                       0.91 (0.40--2.07)                  0.822                                          
  **Month of onset**                                                                                                  0.918                                          
  December 2012                       166 (99.4)     1 (0.6)                       1                                                                                 
  January                             692 (99.4)     4 (0.6)                       0.96 (0.11--8.64)                  0.971                                          
  February                            593 (99.5)     3 (0.5)                       0.84 (0.09--8.13)                  0.880                                          
  March                               647 (99.7)     2 (0.3)                       0.51 (0.05--5.69)                  0.587                                          
  April                               595 (99.7)     2 (0.3)                       0.56 (0.05--6.19)                  0.635                                          
  May                                 640 (99.7)     2 (0.3)                       0.52 (0.05--5.76)                  0.593                                          
  June                                945 (99.8)     2 (0.2)                       0.35 (0.03--3.90)                  0.394                                          
  July                                985 (99.9)     1 (0.1)                       0.17 (0.01--2.71)                  0.209                                          
  August                              1008 (99.5)    5 (0.5)                       0.82 (0.10--7.09)                  0.860                                          
  September                           1188 (99.7)    4 (0.3)                       0.56 (0.06--5.03)                  0.604                                          
  October                             1700 (99.7)    5 (0.3)                       0.49 (0.06--4.20)                  0.514                                          
  November                            2080 (99.8)    4 (0.2)                       0.32 (0.04--2.87)                  0.308                                          
  December                            1799 (99.7)    6 (0.3)                       0.55 (0.07--4.63)                  0.585                                          
  **Headache**                                                                                                                                                       
  YES                                 9937 (99.7)    28 (0.3)                      1                                            1                                    
  NO                                  3101 (99.6)    13 (0.4)                      1.48 (0.77--2.88)                  0.237     1.46 (0.73--2.93)                    0.283
  **Suborbital Pain**                                                                                                                                                
  YES                                 637 (99.8)     1 (0.2)                       1                                                                                 
  NO                                  12401 (99.7)   40 (0.3)                      2.05 (0.28--14.97)                 0.477                                          
  **Body or Joint Ache**                                                                                                                                             
  YES                                 11390 (99.7)   31 (0.3)                      1                                            1                                    
  NO                                  1648 (99.4)    10 (0.6)                      2.23 (1.09--4.56)                  0.028     1.95 (0.90--4.25)                    0.091
  **Nausea and/or vomiting**                                                                                                                                         
  YES                                 4171 (99.6)    18 (0.4)                      1.66 (0.90--3.09)                  0.106     1.38 (0.72--2.67)                    0.327
  NO                                  8867 (99.7)    23 (0.3)                      1                                            1                                    
  **Rash**                                                                                                                                                           
  YES                                 1967 (99.6)    7 (0.4)                       1.16 (0.51--2.62)                  0.723                                          
  NO                                  11071 (99.7)   34 (0.3)                      1                                                                                 
  **Abdominal symptoms**                                                                                                                                             
  YES                                 3848 (99.7)    11 (0.3)                      0.87 (0.44--1.75)                  0.707                                          
  NO                                  9190 (99.7)    30 (0.3)                      1                                                                                 
  **Bleeding**                                                                                                                                                       
  YES                                 254 (98.1)     5 (1.9)                       6.99 (2.72--17.96)                 \<0.001   5.84 (2.17--15.70)                   \<0.001
  NO                                  12784 (99.7)   36 (0.3)                      1                                            1                                    
  **Abdominal pain or tenderness**                                                                                                                                   
  YES                                 245 (99.2)     2 (0.8)                       2.68 (0.64--11.15)                 0.176     1.06 (0.19--5.92)                    0.946
  NO                                  12793 (99.7)   39 (0.3)                      1                                            1                                    
  **Persistent vomiting**                                                                                                                                            
  YES                                 23 (92.0)      2 (8.0)                       29.02 (6.61--127.31)               \<0.001   13.34 (1.92--92.95)                  0.009
  NO                                  13015 (99.7)   39 (0.3)                      1                                            1                                    
  **Clinical fluid accumulation**                                                                                                                                    
  YES                                 2 (100.0)      0 (0.0)                                                                                                         
  NO                                  13036 (99.7)   42 (0.3)                                                         1.00                                           
  **Lethargy and/or restlessness**                                                                                                                                   
  YES                                 108 (98.2)     2 (1.8)                       6.14 (1.46--25.75)                 0.013     0.94 (0.10--8.65)                    0.955
  NO                                  12930 (99.7)   39 (0.3)                      1                                            1                                    
  **Liver enlargement 2cm**                                                                                                                                          
  YES                                 3 (100.0)      0 (0.0)                                                                                                         
  NO                                  13035 (99.7)   41 (0.3)                                                         0.999                                          
  **Severe plasma leakage**                                                                                                                                          
  YES                                 8 (80.0)       2 (20.0)                      83.53 (17.19--405.94)              \<0.001   66.68 (9.13--487.23)                 \<0.001
  NO                                  13030 (99.7)   39 (0.3)                      1                                            1                                    
  **Shock**                                                                                                                                                          
  YES                                 0 (0.0)        3 (100.0)                                                        0.999                                          
  NO                                  13038 (99.7)   38 (0.3)                                                                                                        
  **Severe bleeding**                                                                                                                                                
  YES                                 0 (0.0)        0 (0.0)                                                                                                         
  NO                                  13038 (99.7)   41 (0.3)                                                                                                        
  **Organ failure**                                                                                                                                                  
  YES                                 0 (0.0)        1 (100.0)                                                        0.999                                          
  NO                                  13038 (99.7)   40 (0.3)                                                                                                        

[Table 4](#pone.0157631.t004){ref-type="table"} shows the univariate and multivariate analysis of possible factors of probably dengue-related mortality in the overall study population. Multivariate analysis shows that increasing age, female gender, nausea and/or vomiting, bleeding, lethargy and/or restlessness, severe plasma leakage and shock were associated with mortality.

10.1371/journal.pone.0157631.t004

###### Univariate and multivariate analysis (n = 43343) of probable dengue-related mortality.
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  Variables                           Alive n (%)    Dengue-related death, n (%)   Univariate analysis, OR (95% CI)   p         Multivariate analysis, OR (95% CI)   p
  ----------------------------------- -------------- ----------------------------- ---------------------------------- --------- ------------------------------------ ---------
  **Mean Age, years (SD)**            30.0 (15.7)    41.8 (20.5)                   1.04 (1.03--1.05)                  \<0.001   1.04 (1.03--1.06)                    \<0.001
  **Gender**                                                                                                                                                         
  Male                                26042 (99.8)   42 (0.2)                      1                                            1                                    
  Female                              17209 (99.7)   50 (0.3)                      1.80 (1.20--2.72)                  0.005     1.53 (1.01--2.33)                    0.047
  **Nationality**                                                                                                                                                    
  Malaysian                           39574 (99.8)   87 (0.2)                      1.62 (0.66--3.98)                                                                 
  Non Malaysian                       3677 (99.9)    5 (0.1)                       1                                  0.297                                          
  **Race (n = 39658)**                                                                                                0.369                                          
  Malay                               23433 (99.8)   50 (0.2)                      1                                                                                 
  Chinese                             10021 (99.8)   24 (0.2)                      1.12 (0.69--1.83)                  0.642                                          
  Indian                              4216 (99.9)    6 (0.1)                       0.67 (0.29--1.56)                  0.349                                          
  Indigenous people                   1652 (99.6)    7 (0.4)                       1.99 (0.90--4.39)                  0.090                                          
  Others                              249 (100.0)    0 (0.0)                       0.00 (0.00)                        0.995                                          
  **Place of dwelling (n = 38080)**                                                                                                                                  
  Urban                               31990 (99.8)   68 (0.2)                      1                                                                                 
  Rural                               6005 (99.7)    17 (0.3)                      1.33 (0.78--2.27)                  0.291                                          
  **Month of onset**                                                                                                  0.752                                          
  December 2012                       486 (99.8)     1 (0.2)                       1                                                                                 
  January                             2283 (99.8)    5 (0.2)                       1.30 (0.38--4.51)                  0.675                                          
  February                            1751 (99.7)    5 (0.3)                       0.68 (0.16--2.87)                  0.605                                          
  March                               2000 (99.9)    3 (0.1)                       0.71 (0.17--2.96)                  0.635                                          
  April                               1938 (99.8)    3 (0.2)                       0.82 (0.22--3.05)                  0.766                                          
  May                                 2230 (99.8)    4 (0.2)                       1.16 (0.37--3.67)                  0.796                                          
  June                                2747 (99.7)    7 (0.3)                       0.65 (0.18--2.44)                  0.528                                          
  July                                2789 (99.9)    4 (0.1)                       1.10 (0.36--3.38)                  0.862                                          
  August                              3309 (99.8)    8 (0.2)                       1.71 (0.63--4.65)                  0.291                                          
  September                           4532 (99.6)    17 (0.4)                      0.85 (0.30--2.41)                  0.759                                          
  October                             7095 (99.8)    12 (0.2)                      0.77 (0.27--2.19)                  0.628                                          
  November                            7095 (99.8)    12 (0.2)                      0.89 (0.31--2.57)                  0.830                                          
  December                            5639 (99.8)    11 (0.2)                      0.94 (0.11--8.06)                  0.955                                          
  **Headache**                                                                                                                                                       
  YES                                 32489 (99.8)   63 (0.2)                      0.69 (0.44--1.07)                  0.688                                          
  NO                                  10402 (99.7)   29 (0.3)                      1                                                                                 
  **Suborbital Pain**                                                                                                                                                
  YES                                 1653 (99.9)    2 (0.1)                       1                                                                                 
  NO                                  41598 (99.8)   90 (0.2)                      1.79 (0.44--7.27)                  0.417                                          
  **Body or Joint Ache**                                                                                                                                             
  YES                                 37134 (99.8)   73 (0.2)                      1                                            1                                    
  NO                                  6117 (99.7)    19 (0.3)                      1.58 (0.95--2.62)                  0.076     1.52 (0.90--2.58)                    0.120
  **Nausea and/or vomiting**                                                                                                                                         
  YES                                 14867 (99.7)   47 (0.3)                      1.99 (1.32--3.00)                  0.001     1.80 (1.17--2.77)                    0.008
  NO                                  28384 (99.8)   45 (0.2)                      1                                            1                                    
  **Rash**                                                                                                                                                           
  YES                                 6689 (99.8)    11 (0.2)                      1                                                                                 
  NO                                  36562 (99.8)   81 (0.2)                      1.35 (0.72--2.53)                  0.354                                          
  **Abdominal symptoms**                                                                                                                                             
  YES                                 12455 (99.8)   31 (0.2)                      1.26 (0.82--1.93)                  0.301                                          
  NO                                  30796 (99.8)   61 (0.2)                      1                                                                                 
  **Bleeding**                                                                                                                                                       
  YES                                 856 (99.2)     7 (0.8)                       4.08 (1.88--8.84)                  \<0.001   3.01 (1.29--7.04)                    0.011
  NO                                  42395 (99.8)   85 (0.2)                      1                                            1                                    
  **Abdominal pain or tenderness**                                                                                                                                   
  YES                                 801 (99.6)     3 (0.4)                       1.79 (0.56--5.66)                  0.324                                          
  NO                                  42450 (99.8)   89 (0.2)                      1                                                                                 
  **Persistent vomiting**                                                                                                                                            
  YES                                 62 (96.9)      2 (3.1)                       15.48 (3.73--64.25)                \<0.001   0.41 (0.01--18.35)                   0.648
  NO                                  43189 (99.8)   90 (0.2)                      1                                            1                                    
  **Clinical fluid accumulation**                                                                                                                                    
  YES                                 2 (100.0)      0 (0.0)                                                                                                         
  NO                                  43249 (99.8)   92 (0.2)                                                         1.00                                           
  **Lethargy and/or restlessness**                                                                                                                                   
  YES                                 310 (98.1)     6 (1.9)                       9.66 (4.19--22.28)                 \<0.001   5.97 (2.26--15.78)                   \<0.001
  NO                                  42491 (99.8)   86 (0.2)                      1                                            1                                    
  **Liver enlargement 2cm**                                                                                                                                          
  YES                                 5 (100.0)      0 (0.0)                                                                                                         
  NO                                  43246 (99.8)   92 (0.2)                                                         0.999                                          
  **Severe plasma leakage**                                                                                                                                          
  YES                                 25 (92.6)      2 (7.4)                       38.42 (8.97--164.63)               \<0.001   14.72 (1.54--140.67)                 0.020
  NO                                  43226 (99.8)   90 (0.2)                      1                                            1                                    
  **Shock**                                                                                                                                                          
  YES                                 1 (25.0)       3 (75.0)                      1457.87 (150.21--14149.51)         \<0.001   1805.37 (125.44--25982.98)           \<0.001
  NO                                  43250 (99.8)   89 (0.2)                      1                                            1                                    
  **Severe bleeding**                                                                                                                                                
  YES                                 0 (0.0)        0 (0.0)                                                                                                         
  NO                                  43251 (99.8)   92 (0.2)                                                                                                        
  **Organ failure**                                                                                                                                                  
  YES                                 1 (50.0)       1 (50.0)                      475.28 (29.50--7656.58)            \<0.001   2.947 (0.00--9.74x10^10^)            0.923
  NO                                  43250 (99.8)   91 (0.2)                      1                                            1                                    

[Table 5](#pone.0157631.t005){ref-type="table"} shows the univariate and multivariate analysis of possible factors of dengue-related mortality in the adult study population (age 15 years and above). Multivariate analysis shows that increasing age, nausea and/or vomiting, lethargy or restlessness, and severe plasma leakage were associated with mortality.

10.1371/journal.pone.0157631.t005

###### Univariate and multivariate analysis (n = 37021) of probable dengue-related mortality in Adults (≥15 years old).
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  Variables                           Alive n (%)    Dengue-related death, n (%)   Univariate analysis, OR (95% CI)   p         Multivariate analysis, OR (95% CI)   p
  ----------------------------------- -------------- ----------------------------- ---------------------------------- --------- ------------------------------------ ---------
  **Mean Age, years (SD)**            33.6 (13.95)   45.2 (18.05)                  1.05 (1.04--1.06)                  \<0.001   1.05 (1.04--1.06)                    \<0.001
  **Gender (n = 37018)**                                                                                                                                             
  Male                                22478 (99.8)   40 (0.2)                      1                                            1                                    
  Female                              14456 (99.7)   44 (0.3)                      1.71 (1.11--2.63)                  0.014     1.34 (0.87--2.08)                    0.190
  **Nationality**                                                                                                                                                    
  Malaysian                           33352 (99.8)   79 (0.2)                      1.70 (0.69--4.19)                  0.252                                          
  Non Malaysian                       3582 (99.9)    5 (0.1)                       1                                                                                 
  **Race (n = 33427)**                                                                                                0.622                                          
  Malay                               19372 (99.8)   45 (0.2)                      1                                                                                 
  Chinese                             8778 (99.8)    22 (0.3)                      1.08 (0.65--1.80)                  0.771                                          
  Indian                              3539 (99.8)    6 (0.2)                       073 (0.31--1.71)                   0.469                                          
  Indigenous people                   1439 (99.6)    6 (0.4)                       1.80 (0.77--4.21)                  0.179                                          
  Others                              220 (100.0)    0 (0.0)                       0                                  0.996                                          
  **Place of dwelling (n = 32570)**                                                                                                                                  
  Urban                               27304 (99.8)   63 (0.2)                      1                                                                                 
  Rural                               5189 (99.7)    14 (0.3)                      1.17 (0.66--2.09)                  0.597                                          
  **Month of onset**                                                                                                  0.660                                          
  December 2012                       407 (99.8)     1 (0.2)                       1                                                                                 
  January                             1938 (99.8)    4 (0.2)                       0.84 (0.09--7.54)                  0.876                                          
  February                            1477 (99.7)    5 (0.3)                       1.38 (0.16--11.83)                 0.770                                          
  March                               1693 (99.9)    2 (0.1)                       0.48 (0.04--5.32)                  0.550                                          
  April                               1644 (99.8)    3 (0.2)                       0.74 (0.08--7.16)                  0.797                                          
  May                                 1933 (99.9)    2 (0.1)                       0.42 (0.04--4.66)                  0.481                                          
  June                                2396 (99.8)    6 (0.2)                       1.02 (0.12--8.49)                  0.986                                          
  July                                2394 (99.8)    4 (0.2)                       0.68 (0.08--6.10)                  0.730                                          
  August                              2867 (99.8)    7 (0.2)                       0.99 (0.12--8.10)                  0.995                                          
  September                           3835 (99.6)    16 (0.4)                      1.79 (0.23--12.84)                 0.608                                          
  October                             5431 (99.8)    12 (0.2)                      0.90 (0.12--6.93)                  0.919                                          
  November                            6114 (99.8)    12 (0.2)                      0.80 (0.10--6.16)                  0.829                                          
  December                            4805 (99.8)    10 (0.2)                      0.85 (0.11--6.63)                  0.874                                          
  **Headache**                                                                                                                                                       
  YES                                 28606 (99.8)   60 (0.2)                      1                                                                                 
  NO                                  8328 (99.7)    24 (0.3)                      1.37 (0.86--2.21)                  0.189                                          
  **Suborbital pain**                                                                                                                                                
  YES                                 1477 (99.9)    2 (0.1)                       1                                                                                 
  NO                                  35457 (99.8)   82 (0.2)                      1.71 (0.42--6.95)                  0.455                                          
  **Body or joint ache**                                                                                                                                             
  YES                                 32353 (99.8)   70 (0.2)                      1                                            1                                    
  NO                                  4581 (99.7)    14 (0.3)                      1.41 (0.80--2.51)                  0.239     1.26 (0.70--2.27)                    0.451
  **Nausea and/or vomiting**                                                                                                                                         
  YES                                 12422 (99.7)   42 (0.3)                      1.97 (1.229--3.03)                 0.002     1.90 (1.22--2.98)                    0.005
  NO                                  24512 (99.8)   42 (0.2)                      1                                            1                                    
  **Rash**                                                                                                                                                           
  YES                                 5449 (99.8)    9 (0.2)                       1                                                                                 
  NO                                  31485 (99.8)   75 (0.2)                      1.44 (0.77--2.88)                  0.300                                          
  **Abdominal symptoms**                                                                                                                                             
  YES                                 10493 (99.7)   27 (0.3)                      1.19 (0.76--1.89)                  0.449                                          
  NO                                  26441 (99.8)   57 (0.2)                      1                                                                                 
  **Bleeding**                                                                                                                                                       
  YES                                 750 (99.5)     4 (0.5)                       2.41 (0.88--6.60)                  0.086     1.95 (0.68--5.59)                    0.213
  NO                                  26184 (99.8)   80 (0.2)                      1                                            1                                    
  **Abdominal pain or tenderness**                                                                                                                                   
  YES                                 670 (99.6)     3 (0.4)                       2.01 (0.63--6.36)                  0.238     1.05 (0.28--3.98)                    0.943
  NO                                  36264 (99.8)   81 (0.2)                      1                                            1                                    
  **Persistent vomiting**                                                                                                                                            
  YES                                 50 (96.2)      2 (3.8)                       17.99 (4.31--75.17)                \<0.001   2.99 (0.34--26.38)                   0.325
  NO                                  36884 (99.8)   82 (0.2)                      1                                            1                                    
  **Clinical fluid accumulation**                                                                                                                                    
  YES                                 2 (100.0)      0 (0.0)                                                                                                         
  NO                                  36932 (99.8)   84 (0.2)                                                         1.00                                           
  **Lethargy and/or restlessness**                                                                                                                                   
  YES                                 251 (97.7)     6 (2.3)                       11.24 (4.86--26.03)                \<0.001   5.98 (2.13--16.81)                   0.001
  NO                                  36683 (99.8)   78 (0.2)                      1                                            1                                    
  **Liver enlargement 2cm**                                                                                                                                          
  YES                                 2 (100.0)      0 (0.0)                                                                                                         
  NO                                  36932 (99.8)   84 (0.2)                                                         1.00                                           
  **Severe plasma leakage**                                                                                                                                          
  YES                                 17 (89.5)      2 (10.5)                      52.97 (12.04--232.93)              \<0.001   23.32 (2.58--229.10)                 0.005
  NO                                  36917 (99.8)   82 (0.2)                      1                                            1                                    
  **Shock**                                                                                                                                                          
  YES                                 1 (50.0)       1 (50.0)                      444.98 (27.60--7173.74)            \<0.001   2.19 (0.00--22954.64)                0.868
  NO                                  36933 (99.8)   83 (0.2)                      1                                            1                                    
  **Severe bleeding**                                                                                                                                                
  YES                                 0 (0.0)        0 (0.0)                                                                                                         
  NO                                  36934 (99.8)   84 (0.2)                                                                                                        
  **Organ failure**                                                                                                                                                  
  YES                                 1 (50.0)       1 (50.0)                      444.98 (27.60--7173.74)            \<0.001   27.72 (0.00--235825.80)              0.472
  NO                                  36933 (99.8)   83 (0.2)                      1                                            1                                    

Discussion {#sec008}
==========

The large cohort is a reflection of the increase in the incidence of dengue in the past decade \[[@pone.0157631.ref015]\]. The case fatality rate of 2 in a thousand is consistent with that found over the years since 2001 \[[@pone.0157631.ref006], [@pone.0157631.ref007]\]. With proper identification of factors associated with dengue mortality, time and resources can be focused on those at highest risk.

Our findings show that among those who were serologically confirmed, increasing age, persistent vomiting, bleeding and severe plasma leakage were independently associated with mortality. This differed from the overall study population because it included persistent vomiting, and excluded female gender, nausea and/or vomiting, lethargy and/or restlessness and shock. These added factors are non-specific and one possible explanation is that the death could have been due to other non-dengue illnesses. However, there were only 41 deaths in the serologically confirmed group which represented 44.6% of overall deaths. Only 30.2% of the entire study population (13081 of 43343) were serologically positive. The relatively small number of deaths which is the outcome of interest limits the prognostic information available even with the large study population. We included data from the entire study population as the diagnosis was made based on the WHO clinical criteria for dengue. For those with serological results, 91.3% were positive showing that clinical diagnosis is highly predictive of dengue. Determination of early warning symptoms and signs in the overall population regardless of serological confirmation is crucial in actual clinical practice as this is the population that presents to primary care. The burden of caring for those who are clinically suspected to have dengue is overwhelming as many of the early symptoms and signs are non-specific. Yet, dengue is endemic and is potentially fatal. Early warning symptoms and signs can help the primary care practitioner to identify those who are at greater risk of complications even when diagnostic test results are not available.

We found that increasing age was associated with mortality in the serologically confirmed as well as the overall study cohort. The mean age of those who died from dengue was 12 years greater than those who survived. The number of children who died from dengue in this study population was very small and we were unable to perform a multivariate analysis on this sub-group. In the multivariate analysis of the adult subgroup, increasing age remained a significant associated factor. Older age was found to be associated with severe dengue in France \[[@pone.0157631.ref011]\]. This differed from a study in Vietnam which found that mortality was highest in young children \[[@pone.0157631.ref012]\]. A meta-analysis by Huy et al found that age was negatively associated with dengue shock syndrome. However, there was high heterogeneity and this association was mainly seen in studies on children. They were unable to analyse the age factor in adults \[[@pone.0157631.ref013]\]. The number of children who died from dengue in this study population was very small and we were unable to perform any analysis in this sub-group.

Although gender was associated with mortality in the overall study population, this was not seen in the subgroup analysis for adult nor the serologically confirmed group. Studies have conflicting evidence on the association of gender with severe dengue or dengue-related death. A meta-analysis, and studies in Singapore and Vietnam found that female gender was associated with severe dengue \[[@pone.0157631.ref012], [@pone.0157631.ref013], [@pone.0157631.ref016]\]. However, a study in France showed that male gender was associated with severe dengue manifestations \[[@pone.0157631.ref011]\]. It is unclear as to the mechanism by which age and gender affects the disease manifestation and outcomes. Studies have reported that gender differences could be due to differences in physiology \[[@pone.0157631.ref017]\] or health seeking behavior \[[@pone.0157631.ref013], [@pone.0157631.ref016]\].

This study found that persistent vomiting, bleeding and severe plasma leakage was associated with dengue-related mortality in the serologically confirmed group while nausea and/or vomiting, bleeding, lethargy, severe plasma leakage and shock were associated with dengue-related mortality in the overall population. Of these, only nausea and/or vomiting has not been included as a warning sign in guideline recommendations \[[@pone.0157631.ref006]\]. Nausea and/or vomiting should be considered as an early warning sign that can alert the attending health care practitioner to monitor such patients closely. Nausea and vomiting were also found to be associated with dengue shock syndrome in a meta-analysis and other studies \[[@pone.0157631.ref013], [@pone.0157631.ref018]\]. These symptoms could lead to reduced fluid intake and hence dehydration and serious complications during the phase of plasma leakage. Primary care practitioners should be alerted to these warning signs, as they are the first line contacts for these patients at risk. Bleeding, shock and severe plasma leakage are late manifestations. It is important to detect bleeding and plasma leakage early by monitoring hematocrit levels frequently. Frequent testing during the critical period will guide clinicians in adjusting the rate of intravenous fluid replacement to prevent severe plasma leakage and therefore avert shock. Thrombocytopenia is also useful in detecting early plasma leakage and bleeding. Thus, a complete blood count with haematocrit, white cell and platelet counts is a simple laboratory test that is worth doing to detect and avert these complications \[[@pone.0157631.ref019]\].

As our data were obtained at notification, some patients presented late in the disease process. Hence the public needs to be educated about dengue and its presentation so that they seek treatment earlier.

We found that the incidence of dengue was greater in the later part of the year. There is evidence that dengue incidence is associated with climatic factors, such as temperature and rainfall \[[@pone.0157631.ref015], [@pone.0157631.ref020]\]. A study in Malaysia showed that rainfall peaked in April and through October to December \[[@pone.0157631.ref021]\].

Strengths and limitation {#sec009}
------------------------

The large database of more than 40 000 individuals with significant numbers of mortality enabled the identification of its independent associated factors.

In the process of data cleaning, we found that important factors such as blood indices (platelet count, haematocrit and white cell count) could not be used due to data input error. For example, platelet count were entered as 1.39, 139 or 139 000. In order to ensure that the data were clean, we omitted those variables that could not be verified. Hospitalisation was not captured as a variable in the database and therefore could not be used as a study outcome.

Recommendation {#sec010}
--------------

We recommend that further training be given to those who enter the data. A glossary of variables for the database should be developed. In addition, data that is entered needs to be verified by a medical personnel before final entry.

For clinical practice, doctors treating dengue especially those working in the front-line should be made aware of the independent associated factors of dengue mortality. Future studies should include death cases from other years as different serotypes may predominate in different years.

Conclusion {#sec011}
----------

The case fatality rate remains at 2 in a thousand in this cohort. Older persons and patients with persistent vomiting, bleeding or severe plasma leakage, which were associated with mortality, at notification should be monitored closely and referred early for hospitalisation.
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